Source: Pharmaceutical Development and Technology. Unidade: FCF
Assunto: ANTIFÚNGICOS (TERAPIA)
ABNT
PINHEIRO, Vanessa Alves et al. Development of ciclopirox olamine topical formulations: evaluation of drug release, penetration and cutaneous retention. Pharmaceutical Development and Technology, v. 20, n. 2, p. 197-203, 2015Tradução . . Disponível em: https://doi.org/10.3109/10837450.2013.860544. Acesso em: 04 nov. 2024.APA
Pinheiro, V. A., Serikaku, D., Baby, A. R., Velasco, M. V. R., Kaneko, T. M., & Consiglieri, V. O. (2015). Development of ciclopirox olamine topical formulations: evaluation of drug release, penetration and cutaneous retention. Pharmaceutical Development and Technology, 20( 2), 197-203. doi:10.3109/10837450.2013.860544NLM
Pinheiro VA, Serikaku D, Baby AR, Velasco MVR, Kaneko TM, Consiglieri VO. Development of ciclopirox olamine topical formulations: evaluation of drug release, penetration and cutaneous retention [Internet]. Pharmaceutical Development and Technology. 2015 ; 20( 2): 197-203.[citado 2024 nov. 04 ] Available from: https://doi.org/10.3109/10837450.2013.860544Vancouver
Pinheiro VA, Serikaku D, Baby AR, Velasco MVR, Kaneko TM, Consiglieri VO. Development of ciclopirox olamine topical formulations: evaluation of drug release, penetration and cutaneous retention [Internet]. Pharmaceutical Development and Technology. 2015 ; 20( 2): 197-203.[citado 2024 nov. 04 ] Available from: https://doi.org/10.3109/10837450.2013.860544